Free Trial

89bio (ETNB) News Today

89bio logo
$8.61 -0.12 (-1.37%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$8.00 -0.61 (-7.08%)
As of 05/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
89bio (NASDAQ:ETNB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.50) by $0.01. During the same period in the prior year, the firm posted ($0.54) earnings per share.
89bio, Inc. stock logo
Equities Analysts Issue Forecasts for 89bio FY2025 Earnings
89bio, Inc. (NASDAQ:ETNB - Free Report) - Cantor Fitzgerald issued their FY2025 earnings per share estimates for 89bio in a research note issued on Wednesday, April 30th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will earn ($3.35) per share for the year. Cantor Fitzgerald h
89bio, Inc. stock logo
Ally Bridge Group NY LLC Takes Position in 89bio, Inc. (NASDAQ:ETNB)
Ally Bridge Group NY LLC purchased a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 317,833 shares of the company's stock, valued a
89bio, Inc. stock logo
PDT Partners LLC Cuts Stake in 89bio, Inc. (NASDAQ:ETNB)
PDT Partners LLC reduced its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 52.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,918 shares of the company's stock after selling 88,327 shares d
89bio, Inc. stock logo
Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to "Strong-Buy"
Cantor Fitzgerald raised shares of 89bio to a "strong-buy" rating in a research note on Wednesday.
89bio, Inc. stock logo
89bio (ETNB) Projected to Post Quarterly Earnings on Thursday
89bio (NASDAQ:ETNB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-89bio-inc-stock/)
89bio, Inc. stock logo
Adage Capital Partners GP L.L.C. Sells 525,000 Shares of 89bio, Inc. (NASDAQ:ETNB)
Adage Capital Partners GP L.L.C. lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 60.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 350,000 shares of the company's stock after selling 525,000 s
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Stock Price Up 4.5% - Time to Buy?
89bio (NASDAQ:ETNB) Stock Price Up 4.5% - Time to Buy?
89bio, Inc. stock logo
Raymond James Financial Inc. Acquires Shares of 377,370 89bio, Inc. (NASDAQ:ETNB)
Raymond James Financial Inc. bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 377,370 shares of the company's stock, valued at approximately
89bio, Inc. stock logo
Barclays PLC Buys 425,206 Shares of 89bio, Inc. (NASDAQ:ETNB)
Barclays PLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 198.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 639,974 shares of the company's stock after pur
89bio, Inc. stock logo
89bio's (ETNB) "Sell (D-)" Rating Reiterated at Weiss Ratings
Weiss Ratings reissued a "sell (d-)" rating on shares of 89bio in a research report on Thursday.
89bio, Inc. stock logo
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 210.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 308,459 shares of the company's stock after acquiring
89bio, Inc. stock logo
Investors Buy Large Volume of 89bio Put Options (NASDAQ:ETNB)
89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors purchased 12,935 put options on the stock. This is an increase of 1,544% compared to the average daily volume of 787 put options.
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Trading Up 6.1% - Time to Buy?
89bio (NASDAQ:ETNB) Stock Price Up 6.1% - Time to Buy?
89bio, Inc. stock logo
Avoro Capital Advisors LLC Makes New Investment in 89bio, Inc. (NASDAQ:ETNB)
Avoro Capital Advisors LLC purchased a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,100,000 shares of the company's stock, valued at approximately $32,
89bio, Inc. stock logo
Rock Springs Capital Management LP Makes New Investment in 89bio, Inc. (NASDAQ:ETNB)
Rock Springs Capital Management LP purchased a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 552,741 shares of the company's stock, valued at app
89bio, Inc. stock logo
Geode Capital Management LLC Grows Position in 89bio, Inc. (NASDAQ:ETNB)
Geode Capital Management LLC raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 6.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,207,608 shares of the company's stock after acquiring an additional
89bio, Inc. stock logo
Short Interest in 89bio, Inc. (NASDAQ:ETNB) Grows By 38.3%
89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 15,230,000 shares, an increase of 38.3% from the March 15th total of 11,010,000 shares. Based on an average daily trading volume, of 2,540,000 shares, the short-interest ratio is currently 6.0 days. Currently, 14.8% of the shares of the company are sold short.
89bio, Inc. stock logo
University of Wisconsin Foundation Purchases 193,225 Shares of 89bio, Inc. (NASDAQ:ETNB)
University of Wisconsin Foundation raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 26.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 917,357 shares of the company's stock after acquiring an additional 193,225 shares d
89bio, Inc. stock logo
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Alliancebernstein L.P.
Alliancebernstein L.P. boosted its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 77.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,042,136 shares of the company's stock after purchasing an additional 455,074 shares during the period. Alliancebernstei
89bio, Inc. stock logo
Vanguard Group Inc. Grows Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)
Vanguard Group Inc. grew its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 13.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,692,331 shares of the company's stock after buying an additional 686,054 shares during the p
89bio, Inc. stock logo
89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of "Moderate Buy" by Analysts
89bio, Inc. (NASDAQ:ETNB - Get Free Report) has received an average rating of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommen
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Sets New 1-Year Low - Time to Sell?
89bio (NASDAQ:ETNB) Sets New 12-Month Low - What's Next?
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings
Weiss Ratings reaffirmed a "sell (d-)" rating on shares of 89bio in a research note on Tuesday.
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Shares Down 6.1% - Should You Sell?
89bio (NASDAQ:ETNB) Trading Down 6.1% - Here's What Happened
89bio, Inc. stock logo
ADAR1 Capital Management LLC Has $4.03 Million Holdings in 89bio, Inc. (NASDAQ:ETNB)
ADAR1 Capital Management LLC grew its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7,752.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 515,138 shares of the company's stock after purchasing an additional
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Reaches New 52-Week Low - Should You Sell?
89bio (NASDAQ:ETNB) Sets New 1-Year Low - Here's What Happened
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Trading 5.3% Higher - Still a Buy?
89bio (NASDAQ:ETNB) Trading Up 5.3% - Should You Buy?
89bio, Inc. stock logo
Pictet Asset Management Holding SA Sells 239,574 Shares of 89bio, Inc. (NASDAQ:ETNB)
Pictet Asset Management Holding SA lowered its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,007,034 sha
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Trading Down 8.8% - Should You Sell?
89bio (NASDAQ:ETNB) Stock Price Down 8.8% - Should You Sell?
89bio, Inc. stock logo
Raymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB)
Raymond James Financial Inc. bought a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 377,370 shares of the company's stock, valued at approximately $2,951,000. Ra
ETNB Crosses Above Key Moving Average Level
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Trading Up 4.9% - Time to Buy?
89bio (NASDAQ:ETNB) Stock Price Up 4.9% - Should You Buy?
89bio, Inc. stock logo
47,469 Shares in 89bio, Inc. (NASDAQ:ETNB) Acquired by BIT Capital GmbH
BIT Capital GmbH acquired a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 47,469 shares of the company's stock, valued at approximately $371,000. Several
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Shares Down 5.7% - Should You Sell?
89bio (NASDAQ:ETNB) Stock Price Down 5.7% - Here's What Happened
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Given Sell (D-) Rating at Weiss Ratings
Weiss Ratings reiterated a "sell (d-)" rating on shares of 89bio in a report on Saturday.
89bio, Inc. stock logo
89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by Brokerages
89bio, Inc. (NASDAQ:ETNB - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has
89bio, Inc. stock logo
89bio, Inc. (NASDAQ:ETNB) Shares Sold by Steward Partners Investment Advisory LLC
Steward Partners Investment Advisory LLC trimmed its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 74.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,210 shares of the compa
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Coverage Initiated by Analysts at The Goldman Sachs Group
The Goldman Sachs Group initiated coverage on shares of 89bio in a research report on Friday. They set a "neutral" rating and a $11.00 price objective for the company.
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Shares Gap Up - Time to Buy?
89bio (NASDAQ:ETNB) Shares Gap Up - Here's Why
89bio, Inc. stock logo
89bio (NASDAQ:ETNB) Now Covered by Citigroup
Citigroup assumed coverage on shares of 89bio in a research note on Thursday. They issued a "buy" rating and a $25.00 price target on the stock.
89bio initiated with a Neutral at Goldman Sachs
89bio (ETNB) Receives a New Rating from Goldman Sachs
89bio initiated with a Buy at Citi
Get 89bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter.

ETNB Media Mentions By Week

ETNB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ETNB
News Sentiment

1.31

0.72

Average
Medical
News Sentiment

ETNB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ETNB Articles
This Week

17

5

ETNB Articles
Average Week

Get 89bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ETNB) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners